Review



c6 rat glial cells  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    ATCC c6 rat glial cells
    C6 Rat Glial Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1936 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c6 rat glial cells/product/ATCC
    Average 96 stars, based on 1936 article reviews
    c6 rat glial cells - by Bioz Stars, 2026-06
    96/100 stars

    Images



    Similar Products

    c6 rat glial cells  (ATCC)
    96
    ATCC c6 rat glial cells
    C6 Rat Glial Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c6 rat glial cells/product/ATCC
    Average 96 stars, based on 1 article reviews
    c6 rat glial cells - by Bioz Stars, 2026-06
    96/100 stars
    		  Buy from Supplier
    rat glial glioblastoma c6 cell lines  (Korean Cell Line Bank)
    86
    Korean Cell Line Bank rat glial glioblastoma c6 cell lines
    Specific binding and quantification of dye–labeled aptamers in U87MG (human astrocytic <t>glioblastoma)</t> and <t>C6</t> (rat glial glioblastoma) cells. (A, B) Representative FL images of U87MG and C6 cells treated with Alexa488–labeled ΔAst17-30 (200 nM) or Tri-ΔAst17-30 (66 nM) aptamers, showing BF, Alexa488 (green), DAPI (blue), and merged channels. Scale bars, 100 μm. (C) Box plots of MFI values of the two aptamers showing significant differences in aptamer binding between U87MG and C6 cells ( p < 0.0001 for both ΔAst17-30 and Tri-ΔAst17-30, N = 12), as well as significant difference in binding strength between the two aptamers in U87MG cells ( p < 0.0001, N = 12). (D) Flow cytometry quantifies Alexa488–positive U87MG and C6 cells after Tri-ΔAst17-30 treatment (final 66 nM), revealing specific aptamer binding in U87MG but not C6 cells. The square gates define the percentage of aptamer-positive cells within the total population, which was 92.9 % for U87MG and 4.73 % for C6, respectively. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
    Rat Glial Glioblastoma C6 Cell Lines, supplied by Korean Cell Line Bank, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rat glial glioblastoma c6 cell lines/product/Korean Cell Line Bank
    Average 86 stars, based on 1 article reviews
    rat glial glioblastoma c6 cell lines - by Bioz Stars, 2026-06
    86/100 stars
    		  Buy from Supplier
    rat glial fibroblast c6 ccl 107 cells  (ATCC)
    96
    ATCC rat glial fibroblast c6 ccl 107 cells
    Specific binding and quantification of dye–labeled aptamers in U87MG (human astrocytic <t>glioblastoma)</t> and <t>C6</t> (rat glial glioblastoma) cells. (A, B) Representative FL images of U87MG and C6 cells treated with Alexa488–labeled ΔAst17-30 (200 nM) or Tri-ΔAst17-30 (66 nM) aptamers, showing BF, Alexa488 (green), DAPI (blue), and merged channels. Scale bars, 100 μm. (C) Box plots of MFI values of the two aptamers showing significant differences in aptamer binding between U87MG and C6 cells ( p < 0.0001 for both ΔAst17-30 and Tri-ΔAst17-30, N = 12), as well as significant difference in binding strength between the two aptamers in U87MG cells ( p < 0.0001, N = 12). (D) Flow cytometry quantifies Alexa488–positive U87MG and C6 cells after Tri-ΔAst17-30 treatment (final 66 nM), revealing specific aptamer binding in U87MG but not C6 cells. The square gates define the percentage of aptamer-positive cells within the total population, which was 92.9 % for U87MG and 4.73 % for C6, respectively. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
    Rat Glial Fibroblast C6 Ccl 107 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rat glial fibroblast c6 ccl 107 cells/product/ATCC
    Average 96 stars, based on 1 article reviews
    rat glial fibroblast c6 ccl 107 cells - by Bioz Stars, 2026-06
    96/100 stars
    		  Buy from Supplier
    rat glial cells (c6)  (Pasteur Institute)
    90
    Pasteur Institute rat glial cells (c6)
    Specific binding and quantification of dye–labeled aptamers in U87MG (human astrocytic <t>glioblastoma)</t> and <t>C6</t> (rat glial glioblastoma) cells. (A, B) Representative FL images of U87MG and C6 cells treated with Alexa488–labeled ΔAst17-30 (200 nM) or Tri-ΔAst17-30 (66 nM) aptamers, showing BF, Alexa488 (green), DAPI (blue), and merged channels. Scale bars, 100 μm. (C) Box plots of MFI values of the two aptamers showing significant differences in aptamer binding between U87MG and C6 cells ( p < 0.0001 for both ΔAst17-30 and Tri-ΔAst17-30, N = 12), as well as significant difference in binding strength between the two aptamers in U87MG cells ( p < 0.0001, N = 12). (D) Flow cytometry quantifies Alexa488–positive U87MG and C6 cells after Tri-ΔAst17-30 treatment (final 66 nM), revealing specific aptamer binding in U87MG but not C6 cells. The square gates define the percentage of aptamer-positive cells within the total population, which was 92.9 % for U87MG and 4.73 % for C6, respectively. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
    Rat Glial Cells (C6), supplied by Pasteur Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rat glial cells (c6)/product/Pasteur Institute
    Average 90 stars, based on 1 article reviews
    rat glial cells (c6) - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    rat c6 glial cells  (ATCC)
    96
    ATCC rat c6 glial cells
    Specific binding and quantification of dye–labeled aptamers in U87MG (human astrocytic <t>glioblastoma)</t> and <t>C6</t> (rat glial glioblastoma) cells. (A, B) Representative FL images of U87MG and C6 cells treated with Alexa488–labeled ΔAst17-30 (200 nM) or Tri-ΔAst17-30 (66 nM) aptamers, showing BF, Alexa488 (green), DAPI (blue), and merged channels. Scale bars, 100 μm. (C) Box plots of MFI values of the two aptamers showing significant differences in aptamer binding between U87MG and C6 cells ( p < 0.0001 for both ΔAst17-30 and Tri-ΔAst17-30, N = 12), as well as significant difference in binding strength between the two aptamers in U87MG cells ( p < 0.0001, N = 12). (D) Flow cytometry quantifies Alexa488–positive U87MG and C6 cells after Tri-ΔAst17-30 treatment (final 66 nM), revealing specific aptamer binding in U87MG but not C6 cells. The square gates define the percentage of aptamer-positive cells within the total population, which was 92.9 % for U87MG and 4.73 % for C6, respectively. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
    Rat C6 Glial Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rat c6 glial cells/product/ATCC
    Average 96 stars, based on 1 article reviews
    rat c6 glial cells - by Bioz Stars, 2026-06
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    Specific binding and quantification of dye–labeled aptamers in U87MG (human astrocytic glioblastoma) and C6 (rat glial glioblastoma) cells. (A, B) Representative FL images of U87MG and C6 cells treated with Alexa488–labeled ΔAst17-30 (200 nM) or Tri-ΔAst17-30 (66 nM) aptamers, showing BF, Alexa488 (green), DAPI (blue), and merged channels. Scale bars, 100 μm. (C) Box plots of MFI values of the two aptamers showing significant differences in aptamer binding between U87MG and C6 cells ( p < 0.0001 for both ΔAst17-30 and Tri-ΔAst17-30, N = 12), as well as significant difference in binding strength between the two aptamers in U87MG cells ( p < 0.0001, N = 12). (D) Flow cytometry quantifies Alexa488–positive U87MG and C6 cells after Tri-ΔAst17-30 treatment (final 66 nM), revealing specific aptamer binding in U87MG but not C6 cells. The square gates define the percentage of aptamer-positive cells within the total population, which was 92.9 % for U87MG and 4.73 % for C6, respectively. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

    Journal: Materials Today Bio

    Article Title: Y-shaped trivalent aptamer for targeted visualization and tracking of reprogrammed astrocytes

    doi: 10.1016/j.mtbio.2025.102482

    Figure Lengend Snippet: Specific binding and quantification of dye–labeled aptamers in U87MG (human astrocytic glioblastoma) and C6 (rat glial glioblastoma) cells. (A, B) Representative FL images of U87MG and C6 cells treated with Alexa488–labeled ΔAst17-30 (200 nM) or Tri-ΔAst17-30 (66 nM) aptamers, showing BF, Alexa488 (green), DAPI (blue), and merged channels. Scale bars, 100 μm. (C) Box plots of MFI values of the two aptamers showing significant differences in aptamer binding between U87MG and C6 cells ( p < 0.0001 for both ΔAst17-30 and Tri-ΔAst17-30, N = 12), as well as significant difference in binding strength between the two aptamers in U87MG cells ( p < 0.0001, N = 12). (D) Flow cytometry quantifies Alexa488–positive U87MG and C6 cells after Tri-ΔAst17-30 treatment (final 66 nM), revealing specific aptamer binding in U87MG but not C6 cells. The square gates define the percentage of aptamer-positive cells within the total population, which was 92.9 % for U87MG and 4.73 % for C6, respectively. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

    Article Snippet: Human astrocytic glioblastoma U-87MG and rat glial glioblastoma C6 cell lines were acquired form the Korean Cell Line Bank (Seoul, Korea).

    Techniques: Binding Assay, Labeling, Flow Cytometry